Ottis Philipp, Toure Momar, Cromm Philipp M, Ko Eunhwa, Gustafson Jeffrey L, Crews Craig M
Department of Molecular, Cellular and Developmental Biology, Yale University , New Haven, Connecticut, United States.
Department of Chemistry, Yale University , New Haven, Connecticut, United States.
ACS Chem Biol. 2017 Oct 20;12(10):2570-2578. doi: 10.1021/acschembio.7b00485. Epub 2017 Sep 5.
Proteolysis targeting chimera (PROTAC) technology, the recruitment of E3 ubiquitin ligases to induce the degradation of a protein target, is rapidly impacting chemical biology, as well as modern drug development. Here, we explore the universality of this approach by evaluating different E3 ubiquitin ligases, engineered in their substrate binding domains to accept a recruiting ligand. Five out of six E3 ligases were found to be amenable to recruitment for target degradation. Taking advantage of the tight spatiotemporal control of inducing ubiquitination on a preselected target in living cells, we focused on two of the engineered E3 ligases, βTRCP and parkin, to unravel their ubiquitination characteristics in comparison with the PROTAC-recruited endogenous E3 ligases VHL and cereblon.
蛋白酶靶向嵌合体(PROTAC)技术,即招募E3泛素连接酶以诱导蛋白质靶标降解,正在迅速影响化学生物学以及现代药物开发。在此,我们通过评估不同的E3泛素连接酶来探索这种方法的通用性,这些E3泛素连接酶在其底物结合结构域中经过工程改造以接受招募配体。发现六种E3连接酶中有五种适合用于招募以进行靶标降解。利用在活细胞中对预选靶标诱导泛素化的严格时空控制,我们重点研究了两种经过工程改造的E3连接酶βTRCP和帕金森蛋白,以与PROTAC招募的内源性E3连接酶VHL和cereblon相比,揭示它们的泛素化特征。